IP Library Granted Patent US 6,958,220
Granted Patent B2
US 6,958,220 · App. 10/050,425 · Granted Oct 25, 2005

Inhibitors of proteasomal activity for stimulating hair growth

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,958,220
App. No.
10/050,425
Granted
Oct 25, 2005
Kind
B2
Abstract

This inventions relates to compounds that inhibit the activity of the proteasome and both promotes hair growth and stimulates the production of hair follicles. The compounds provided herein are thus useful in stimulating hair growth, including hair density, in subject where this is desirable.

Claims (8)

1. A method to treat a mammalian subject for a condition benefited by stimulating hair growth which method comprises administering to said mammalian subject in need of such treatment an effective amount of a compound that inhibits proteasomal activity, wherein said compound is a peptidyl aldehyde or a peptidyl epoxy ketone.

2. The method of claim 1 , wherein said subject is a human.

3. The method of claim 1 , wherein said condition to be treated is selected from the group consisting of male pattern baldness, alopecia caused by chemotherapy, hair thinning due to aging, and genetic disorders.

4. The method of claim 1 , wherein said subject is a non-human mammal.

5. The method of claim 4 , wherein said hair growth provides additional protection from cold temperatures.

6. The method of claim 1 , wherein said hair growth is due to thickened hair sheath diameter, increased hair diameter, differentiation of quiescent hair follicles into more mature forms, increased rate of growth in hair length and/or thickness, or the appearance of proliferation of new hair follicles.

7. The method of claim 1 , wherein said compound is co-administered with an agent promoting skin tissue growth or infiltration.

8. The method of claim 7 , wherein said agent is selected from the group consisting of an epidermal growth factor, a fibroblast growth factor, a platelet-derived growth factor, a transforming growth factor, a parathyroid hormone, a leukemia inhibitory factor, and an insulin-like growth factor.